69 related articles for article (PubMed ID: 13191594)
1. [Practical results of use of triethylenemelamine in neoplastic diseases. III. Lymphosarcoma and reticulosarcoma].
LENTI G; GAVOSTO F
G Ital Chemioter; 1954; 1(1):103-4. PubMed ID: 13191594
[No Abstract] [Full Text] [Related]
2. [Effect of TEM on chronic leukemia, lymphogranulomatosis and lymphosarcoma].
HAEHNER E; HEINEN W; LOOSEN H; SCHMIDT H
Med Klin; 1954 May; 49(21):853-4; passim. PubMed ID: 13164965
[No Abstract] [Full Text] [Related]
3. Treatment of lymphomatous diseases with triethylene melamine.
MEYER LM; SCHWARTZ SO; SAWITSKY A; BEYERS MR; RITZ ND; BRAHIN C; DIEFENBACH W; KLEINSCHMIDT W; FRIEDMAN I
Acta Med Scand Suppl; 1952; 272():1-36. PubMed ID: 13039963
[No Abstract] [Full Text] [Related]
4. Triethylenemelamine and its associations in the treatment of hemolymphoblastoses and other neoplasms.
MARMONT A; FUSCO F
G Ital Chemioter; 1954; 1(1):193-5. PubMed ID: 13191624
[No Abstract] [Full Text] [Related]
5. [Treatment of hemoblastosis with triethylene melamine].
LINKE A; LASCH HG
Dtsch Med Wochenschr; 1953 Jun; 78(25):911-6. PubMed ID: 13068032
[No Abstract] [Full Text] [Related]
6. Clinical and hematologic effects of triethylene melamine.
AXELROD AR; BERMAN L; MURPHY RV
Am J Med; 1953 Nov; 15(5):684-94. PubMed ID: 13104437
[No Abstract] [Full Text] [Related]
7. [Clinical trials with triethylene melamine].
FERRARI M; KASDORF H
Arch Urug Med Cir Espec; 1953; 42(3-4):134-44. PubMed ID: 14350952
[No Abstract] [Full Text] [Related]
8. Triethylene melamine (TEM) in the treatment of malignant lymphoid disease.
HAMBLY CK; ROBERTSON TI
Med J Aust; 1955 Jun; 42(1 25):900-11. PubMed ID: 13243982
[No Abstract] [Full Text] [Related]
9. [Early resistance to triethylene melamine].
LATTANZI A; PARDELLI G
Riforma Med; 1954 Jan; 68(1):7-12. PubMed ID: 13156339
[No Abstract] [Full Text] [Related]
10. Lymphosarcoma of the tonsil.
GIARDINO JP; BELL DF
Clin Proc Child Hosp Dist Columbia; 1953 May; 9(5):98-103. PubMed ID: 13059922
[No Abstract] [Full Text] [Related]
11. Triethylene melamine in the management of lymphosarcoma.
SAMPEY JR
Va Med Mon (1918); 1960 Aug; 87():448-50. PubMed ID: 13856320
[No Abstract] [Full Text] [Related]
12. [Practical results of use of triethylenemelamine in neoplastic diseases. I. Hodgkin's disease].
LENTI G; GAVOSTO F
G Ital Chemioter; 1954; 1(1):101-2. PubMed ID: 13191592
[No Abstract] [Full Text] [Related]
13. [Practical results of use of triethylenemelamine in neoplastic diseases. II. Chronic leukemia].
LENTI G; GAVOSTO F
G Ital Chemioter; 1954; 1(1):102-3. PubMed ID: 13191593
[No Abstract] [Full Text] [Related]
14. [Our experience with the application of triethylene melamine (TEM) in patients with malignant hemopathies].
RUVIDIC R; NIKOLIC J
Med Glas; 1960 Sep; 14():435-42. PubMed ID: 13744964
[No Abstract] [Full Text] [Related]
15. Preliminary results of chemo-radiotherapy followed or not by active immunotherapy of stage III and IV lymphosarcoma and reticulosarcoma. Correlation of the results with WHO categorisation.
Misset JL; Mathé G; Tubiana M; Caillou B; de Vassal F; Pouillart P; Gil M; Tentas C; Hayat M; Schwarzenberg L; Jasmin C; Delgado M; Machover D; Ribaud P; Musset M
Cancer Chemother Pharmacol; 1978; 1(4):197-202. PubMed ID: 373920
[TBL] [Abstract][Full Text] [Related]
16. [Injury to the hematopoietic system after treatment with triethylene iminotriazine (TEM) in a case of Brill-Symmers disease].
RIEGEL R; KRUCKEMEYER K
Dtsch Med J; 1954 Apr; 5(8):207-11. PubMed ID: 13173321
[No Abstract] [Full Text] [Related]
17. [Practical results of use of triethylenemelamine in neoplastic diseases. IV. Lung neoplasms].
LENTI G; GAVOSTO F
G Ital Chemioter; 1954; 1(1):104-5. PubMed ID: 13191595
[No Abstract] [Full Text] [Related]
18. [X-ray therapy of lymphosarcoma & reticulosarcoma; review of 35 cases treated between 1944 & 1956].
CHIAPPA S; FIOCCHI C
Haematologica; 1957; 42(10):1571-81. PubMed ID: 13480600
[No Abstract] [Full Text] [Related]
19. [Blood proteins in malignant blood diseases. III. The blood protein picture in lymphosarcoma and reticulosarcoma].
GIGANTE D; ROSSI-ESPAGNET A; CAPONE M; MARINONI GF
Prog Med (Napoli); 1954 Dec; 10(23):705-10. PubMed ID: 14357448
[No Abstract] [Full Text] [Related]
20. [Clinical experiences with triethylene melamine in therapy of neoplastic diseases of the blood].
BOCK HE; KIRBERGER E; WOELFFER U
Z Klin Med; 1953; 150(5):482-98. PubMed ID: 13137291
[No Abstract] [Full Text] [Related]
[Next] [New Search]
